Comparing Exergaming and Usual Care Physical Therapy in Nursing Home Residents

April 30, 2026 updated by: University of Castilla-La Mancha

Physical Function in Older Adults: Exergaming vs. Usual Care in Physical Therapy - A Randomized Controlled Trial

The objective of this clinical trial is to compare the effects of exergaming and usual care physical therapy on physical function in older adults residing in nursing homes.

This trial seeks to answer the following key questions:

  • Does physical function differ between interventions after treatment?
  • How do these interventions impact enjoyment of therapy?
  • Are there differences in adherence or perceived exertion between the interventions?

Study Overview

Detailed Description

A single-blind, randomized controlled trial will be conducted to compare exergaming and usual care interventions. Participants will be recruited from nursing homes in the province of Toledo, and the study will follow the CONSORT guidelines for clinical, crossover, and parallel trials.

Two experimental groups will be tested, with interventions performed three days per week for six weeks, each session lasting approximately 30 minutes. The exergaming group will play seven video games from the Party Fowl app, while the usual care group will continue their standard exercise routine.

Outcome measures will be assessed at baseline, post-intervention (6 weeks), and at a 3-month follow-up to evaluate the middle-term effects of both interventions.

Study Type

Interventional

Enrollment (Actual)

78

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Toledo
      • Añover de Tajo, Toledo, Spain, 45250
        • Residencia de Mayores VIVENS
      • Fuensalida, Toledo, Spain, 45510
        • Nueva Esperanza Nursing Home
      • Magán, Toledo, Spain, 45590
        • Residencia Maranatha
      • Manzaneque, Toledo, Spain, 45460
        • Residencial Montes de Toledo
      • Toledo, Toledo, Spain, 45071
        • Universidad de Castilla-La Mancha

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • subjects over 60 years of age
  • score equal to or greater than 20 on the Mini Mental cognitive test
  • Subjects that present the ability to stand without the use of technical aids or with the technical assistance of a device used for walking.

Exclusion Criteria:

  • severe visual impairment
  • medical contraindication for physical activity
  • pathology or problem that could prevent the test from being carried out.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exergaming
This group will perform approximately 28 minutes of exergaming 3 times a week for 6 weeks
Exergaming: Participants will perform different exercises through videogames
Active Comparator: Usual physical therapy care
This group will perform their usual care exercises treatments for approximately 28 minutes for 3 times a week for 6 weeks
Usual care: Different exercises will be performed

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical function
Time Frame: Baseline, post-intervention (6 weeks) and 3 months follow-up.
Physical function will be assessed using the Short Physical Performance Battery (SPPB)
Baseline, post-intervention (6 weeks) and 3 months follow-up.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hand grip strength
Time Frame: Baseline, post-intervention (6 weeks) and 3 months follow-up.
Hand grip strength will be assessed using a hand dynamometer.
Baseline, post-intervention (6 weeks) and 3 months follow-up.
Exercise enjoyment
Time Frame: Post-intervention (6 weeks)
This outcome will be measured Physical Activity Enjoyment Scale (PACES). Higher values indicate higher perceived satisfaction/ enjoyment.
Post-intervention (6 weeks)
Rate of Perceived Exertion
Time Frame: RPE will be measured inmediatley after the intervention
Rate of perceived exertion will be measured using Borg (RPE 1-10). Higher values indicate higher levels of perceived exertion
RPE will be measured inmediatley after the intervention
Adherence
Time Frame: Through study completion (6 weeks), with a final adherence percentage calculated at the end of the intervention.
Adherence will be measured by the percentage of sessions attended of each participant.
Through study completion (6 weeks), with a final adherence percentage calculated at the end of the intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 5, 2025

Primary Completion (Actual)

April 30, 2026

Study Completion (Estimated)

July 30, 2026

Study Registration Dates

First Submitted

March 3, 2025

First Submitted That Met QC Criteria

March 19, 2025

First Posted (Actual)

March 20, 2025

Study Record Updates

Last Update Posted (Actual)

May 1, 2026

Last Update Submitted That Met QC Criteria

April 30, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Data will be provided to other researchers if asked to the principal investigator

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Older Adults Institutionalized in Residential Homes

Clinical Trials on Exergaming

Subscribe